Medicinal Chemistry and Therapeutic Potential of Agonists, Antagonists and Allosteric Modulators of A1 Adenosine Receptor: Current Status and Perspectives
Journal:
Current Pharmaceutical Design
Volume:
25
Page:
2697-2715
Author(s):
Pran Kishore Deb*, Satyendra Deka, Pobitra Borah, Sara N. Abed and Karl-Norbert Klotz
Premature Ovarian Insufficiency and Long-Term Health Consequences
Journal:
Current Vascular Pharmacology
Volume:
17
Page:
604-609
Author(s):
Sophia Tsiligiannis*, Nick Panay and John C. Stevenson
Non-Hormonal Replacement Therapy Regimens: Do they have an Effect on Cardiovascular Risk?
Journal:
Current Vascular Pharmacology
Volume:
17
Page:
573-578
Author(s):
Evangelia Mareti*, Christina Ampatzi, Stavroula A. Paschou, Evangelia Voziki and Dimitrios G. Goulis
Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; Α Randomised Clinical Trial
Journal:
Current Vascular Pharmacology
Volume:
17
Page:
635-643
Author(s):
Kallirroi I. Kalantzi, Ioannis V. Ntalas, Vasileios G. Chantzichristos, Maria E. Tsoumani, Dimitrios Adamopoulos, Christos Asimakopoulos, Adamantios Bourdakis, Petros Darmanis, Alexandra Dimitriadou, Stefanos Gkiokas, Konstantinos Ipeirotis, Kyriaki Kitikidou, Ioannis Klonaris, Aglaia Kostaki, Dimitrios Logothetis, Konstantinos Mainas, Theodoros Mais, Athanasios Maragiannis, Konstantina Martiadou, Konstantinos Mavronasos, Ioannis Michelongonas, Dimitrios Mitropoulos, Georgios Papadimitriou, Achilleas Papadopoulos, Miltiadis Papaioakeim, Kosmas Sofillas, Sotiria Stabola, Emmanouil Stefanakis, Dimitrios Stergiou, Maria Thoma, Alexandros Zenetos, Stergios Zisekas, John A. Goudevenos, Demosthenes B. Panagiotakos and Alexandros D. Tselepis*
Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives
Journal:
Current Vascular Pharmacology
Volume:
17
Page:
546-555
Author(s):
Vasiliki Venetsanaki and Stergios A. Polyzos*
Menopause and its Cardiometabolic Consequences: Current Perspectives
Journal:
Current Vascular Pharmacology
Volume:
17
Page:
543-545
Author(s):
Panagiotis Anagnostis and Dimitrios G. Goulis
Diabetes in Menopause: Risks and Management
Journal:
Current Vascular Pharmacology
Volume:
17
Page:
556-563
Author(s):
Stavroula Α. Paschou *, Panagiotis Anagnostis, Dimitra I. Pavlou, Andromachi Vryonidou, Dimitrios G. Goulis and Irene Lambrinoudaki
Cardiovascular Risk in Postmenopausal Women with Polycystic Ovary Syndrome
Journal:
Current Vascular Pharmacology
Volume:
17
Page:
579-590
Author(s):
Eleni Armeni and Irene Lambrinoudaki*
Cardiovascular Risk in Perimenopausal Women
Journal:
Current Vascular Pharmacology
Volume:
17
Page:
591-594
Author(s):
John C. Stevenson*, Sophia Tsiligiannis and Nick Panay
Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?
Journal:
Current Vascular Pharmacology
Volume:
17
Page:
564-572
Author(s):
Panagiotis Anagnostis*, Stavroula A. Paschou, Niki Katsiki, Dimitrios Krikidis, Irene Lambrinoudaki and Dimitrios G. Goulis